At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Cost-Effectiveness of an Intensive and Abbreviated Individualized Smoking Cessation Support Program Delivered by Pharmacists: A Randomized Controlled Trial
In Brief
A clinical study evaluating Intensive Smoking Cessation Group and Abbreviated Smoking Cessation Group for Smoking Cessation and 2 related conditions. Completed, enrolled 150 participants across 1 site.
Detailed Summary
This study aims to look at the efficacy and impact of a pharmacist-led smoking cessation program. It will assess an intensive program and an abbreviated program, with the latter being evaluated for feasibility in community pharmacies. Participants will be in one of two groups: intensive or abbreviated. Smoking abstinence rates, self-efficacy and overall satisfaction will be compared. Additionally, a cost-effectiveness analysis will be executed to determine the feasibility of customized smoking cessation programs in community pharmacies across Newfoundland and Labrador.
Study Details
Timeline
Interventions
This group will meet with the pharmacist more frequently and for longer periods than other groups.
This group will meet with the pharmacist less frequently and for shorter periods in comparison to the intensive group.